# A Study of E6742 in Participants With Systemic Lupus Erythematosus

> **NCT07515014** · PHASE2 · RECRUITING · sponsor: **Eisai Co., Ltd.** · enrollment: 256 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** E6742
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07515014
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2028-08-05
- **Final completion:** 2029-03-01
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515014, "A Study of E6742 in Participants With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07515014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*